Literature DB >> 21782907

Integration of molecular genetics and proteomics with cell metabolism: how to proceed; how not to proceed!

Leslie C Costello, Renty B Franklin.   

Abstract

There now exists a resurgence of interest in the role of intermediary metabolism in medicine; especially in relation to medical disorders. Coupled with this is the contemporary focus on molecular biology, genetics and proteomics and their integration into studies of regulation and alterations in cellular metabolism in health and disease. This is a marriage that has vast potential for elucidation of the factors and conditions that are involved in cellular metabolic and functional changes, which heretofore could not be addressed by the earlier generations of biochemists who established the major pathways of intermediary metabolism. The achievement of this present potential requires the appropriate application and interpretation of genetic and proteomic studies relating to cell metabolism and cell function. This requires knowledge and understanding of the principles, relationships, and methodology, such as biochemistry and enzymology, which are involved in the elucidation of cellular regulatory enzymes and metabolic pathways. Unfortunately, many and possibly most contemporary molecular biologists are not adequately trained and knowledgeable in these areas of cell metabolism. This has resulted in much too common inappropriate application and misinformation from genetic/proteomic studies of cell metabolism and function. This presentation describes important relationships of cellular intermediary metabolism, and provides examples of the appropriate and inappropriate application of genetics and proteomics. It calls for the inclusion of biochemistry, enzymology, cell metabolism and cell physiology in the graduate and postgraduate training of molecular biology and other biomedical researchers.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782907      PMCID: PMC4041378          DOI: 10.1016/j.gene.2011.06.035

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Metabolomics: building on a century of biochemistry to guide human health.

Authors:  J Bruce German; Bruce D Hammock; Steven M Watkins
Journal:  Metabolomics       Date:  2005-03       Impact factor: 4.290

2.  The effect of contemporary education and training of biomedical scientists on present and future medical research.

Authors:  Leslie C Costello
Journal:  Acad Med       Date:  2009-04       Impact factor: 6.893

3.  Epidemiology faces its limits.

Authors:  G Taubes
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

4.  Pesticide residues and breast cancer?

Authors:  B MacMahon
Journal:  J Natl Cancer Inst       Date:  1994-04-20       Impact factor: 13.506

Review 5.  'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

Review 6.  Testosterone and prolactin regulation of metabolic genes and citrate metabolism of prostate epithelial cells.

Authors:  L C Costello; R B Franklin
Journal:  Horm Metab Res       Date:  2002-08       Impact factor: 2.936

7.  Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues.

Authors:  Keshav K Singh; Mohamed M Desouki; Renty B Franklin; Leslie C Costello
Journal:  Mol Cancer       Date:  2006-04-04       Impact factor: 27.401

8.  Tumor cell metabolism: the marriage of molecular genetics and proteomics with cellular intermediary metabolism; proceed with caution!

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Mol Cancer       Date:  2006-11-07       Impact factor: 27.401

9.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

10.  hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands.

Authors:  Mohamed M Desouki; Joseph Geradts; Beatrice Milon; Renty B Franklin; Leslie C Costello
Journal:  Mol Cancer       Date:  2007-06-05       Impact factor: 27.401

View more
  6 in total

1.  Evidence that Human Prostate Cancer is a ZIP1-Deficient Malignancy that could be Effectively Treated with a Zinc Ionophore (Clioquinol) Approach.

Authors:  Leslie C Costello; Renty B Franklin; Jing Zou; Michael J Naslund
Journal:  Chemotherapy (Los Angel)       Date:  2015-06

Review 2.  Cell metabolomics.

Authors:  Aihua Zhang; Hui Sun; Hongying Xu; Shi Qiu; Xijun Wang
Journal:  OMICS       Date:  2013-08-29

Review 3.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Arch Biochem Biophys       Date:  2016-04-27       Impact factor: 4.013

4.  A review of the important central role of altered citrate metabolism during the process of stem cell differentiation.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  J Regen Med Tissue Eng       Date:  2013-05

5.  A Review of the Current Status and Concept of the Emerging Implications of Zinc and Zinc Transporters in the Development of Pancreatic Cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Pancreat Disord Ther       Date:  2013

6.  Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy!

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Oncol Rev       Date:  2018-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.